
|Articles|January 1, 2003
Botox battles heat up
Author(s)Timothy N. Troy
Palm Beach, Fla. - Dermatologists apparently have had enough hype, spam, and promotion of new retail creams claiming to be "better" than mainstay anti-aging products. The upshot is a first-ever clinical comparison of such topicals to botulinum toxin A, a wrinkle fighter turned household word by Allergan's Botox Cosmetic.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Phase 3 Data Position Zasocitinib as a Potential New Oral Option for Psoriasis
2
Highlighting Major Breakthroughs for Atopic Dermatitis and Psoriasis in 2025
3
First-in-Class Topical GT20029 Demonstrates Promising Phase 2 Efficacy and Tolerability for AGA
4
Topicals Demonstrate Targeted Control Across 3 Distinct Atopic Dermatitis Cases
5

















